The combination of heparin and aspirin is widely regarded as 'standard therapy' to increase rates of live birth in patients with recurrent pregnancy loss and positive antiphospholipid antibodies. However, this recommendation is based largely on expert opinion. Does a meta-analysis of randomized controlled trials support the practice?
- Shari E. Gelber
- Jane E. Salmon
